A guide to drug therapy in patients with enteral feeding tubes: Dosage form selection and administration methods

Hospital Pharmacy

Volumn 32, Issue 1, 1997, Pages 57-64

  Beckwith, Mary Christina ^a   Barton, Richard G ^b   Graves, Caran ^a  

^a UNIVERSITY OF UTAH HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

enteral nutrition; nasoenteric tube

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; AMPHETAMINE DERIVATIVE; ANOREXIGENIC AGENT; ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BELLADONNA ALKALOID; BENZONATATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBIDOPA PLUS LEVODOPA; DIAZEPAM; DISOPYRAMIDE; FLUPHENAZINE; GLIPIZIDE; GUAIFENESIN; LANSOPRAZOLE; LITHIUM; LITHIUM CARBONATE; MEPROBAMATE; METHYLPHENIDATE; MOXASTINE TEOCLATE; MULTIVITAMIN; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NICOTINIC ACID; NITRIC ACID DERIVATIVE; OMEPRAZOLE; ORPHENADRINE CITRATE; PENTOXIFYLLINE; PHENOTHIAZINE DERIVATIVE; PROCAINAMIDE; PROTON PUMP INHIBITOR; PYRIDOSTIGMINE; SALBUTAMOL; SALBUTAMOL SULFATE; SIMETHICONE; THEOPHYLLINE DERIVATIVE; UNINDEXED DRUG;

ARTICLE; DRUG INCOMPATIBILITY; ENTERIC FEEDING; HUMAN; JEJUNOSTOMY; NASOGASTRIC TUBE; ORAL DRUG ADMINISTRATION; OSMOLALITY; PATIENT CARE; SUSTAINED RELEASE PREPARATION;

EID: 0031017558     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rollins CJ. Adult enteral nutrition. In: Koda-Kimble MA, Young LY, eds. Applied Therapeutics: The Clinical Use of Drugs. 6th ed. Vancouver: Applied Therapeutics, Inc.; 1995, 34.1-28.
2. Silberman H. Parenteral and enteral nutrition. 2nd ed. Norwalk: Appleton and Lange; 1989, 117-58.
3. Rombeau JL, Caldwell MD, eds. Enteral and Tube Feeding: Clinical Nutrition. 2nd ed. Philadelphia: W.B. Saunders Company, 1990.
4. Estoup M. Approaches and limitations of medication delivery in patients with enteral feeding tubes. Crit Care Nurse. 1994;14:68-72, 77-79.
5. Gora ML, Tschampel MM, Visconti JA. Considerations of drug therapy in patients receiving enteral nutrition. Nutr Clin Pract. 1989;4:105-110.
6. Klein S, Fleming CR. Enteral and parenteral nutrition. In: Sleisenger MG, Fordtran JM, eds. Gastrointestinal Disease: Pathophysiology/ Diagnosis/Management. 5th ed. Philadelphia: W.B. Saunders Company, 1993:2062-2096.
7. Schuffler MD, Sinanan MN. Intestinal obstruction and pseudo-obstruction. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology/Diagnosis/Management. 5th edition. Philadelphia: W.B. Saunders Company; 1993, 898-916.
8. Mitchell JF. Oral solid dosage forms that should not be crushed: 1996 revision. Hosp Pharm. 1996;31:27-37.
9. OxyContin tablets product information. Norwalk, CT: Purdue Pharma L.P.; December 1995.
10. Personal communication. Alexander CM, Merck Human Health Division. February 23, 1994.
11. McEvoy GK, ed. American Hospital Formulary Service. Bethesda, MD: American Society of Hospital Pharmacists, Inc.; 1996.
12. Personal communication. Clarke CB, TAP Pharmaceuticals Inc., May 22, 1996.
13. Dickerson RN, Melnik G. Osmolality of oral drug solutions and suspensions. Am J Hosp Pharm. 1988;45:832-834.
14. Lutomski DM, Gora ML, Wright SM, Martin JE. Sorbitol content of selected oral liquids. Ann Pharmacother. 1993;27:269-274.
15. Burns PE, McCall L, Wirsching R. Physical compatibility of enterai formulas with various common medications. J Am Diet Assoc. 1988;88:1094-1096.
16. Cutie AJ, Altman E, Lenkel L. Compatibility of enteral products with commonly employed drug additives. JPEN. 1983; 7:186-191.
17. Bauer LA. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurol. 1982:32:570-572.
18. Kutsop JJ. Update on vitamin K1 content of enterai products [letter]. Am J Hosp Pharm. 1984;41:1762.
19. Landau J, Moulds RFW. Warfarin resistance caused by vitamin K in intestinal feeds [letter]. Med J Aust. 1982;263-264.
20. Watson AJM, Pegg M, Green JRB. Enteral feeds may antagonise warfarin. Br Med J. 1984;288:557.
21. Parr MD, Record KE, Griffith GL, Zeok JV, Todd EP. Effect of enterai nutrition on warfarin therapy [letter]. Clin Pharm. 1982;1:274-276.
22. Marcuard SP, Stegall KL, Trogdon S. Clearing obstructed feeding tubes. JPEN. 1989;13:81-83.
23. Bommarito AA, Heinzelmann MJ, Boysen DA. A new approach to the management of obstructed enteral feeding tubes. Nutr Clin Pract. 1989;4:111-114.
24. Bailey K. Management of phytobezoars and clogged feeding tubes. Pharmacy Newsletter, Thomas Jefferson University Hospital. 1994;12:13.
25. Olin BR, Hebel SK, eds. Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons; 1996.